Envoy Medical Receives FDA Approval to Expand Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data
White Bear Lake, Minnesota--(Newsfile Corp. - October 7, 2025) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to expand the Company's pivotal clinical trial for the fully implanted Acclaim® cochlear implant to the final stage based on promising three-month data from the first 10 patients. The
Biotechnology, Healthcare and Hospitals
2025-10-07 8:00 AM EDT | Envoy Medical, Inc.
Cosmo Pharmaceuticals Announces Regulatory Approval of Winlevi(R) in South Korea
Dublin, Ireland--(Newsfile Corp. - October 7, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-driven healthcare and specialty pharmaceuticals, today announced that the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea has approved Winlevi® (clascoterone) cream 1% for the treatment of acne vulgaris in patients aged twelve years and older. This approval marks another important milestone in Cosmo’s global dermatology expansion and r
Healthcare and Hospitals, Health
2025-10-07 1:09 AM EDT | Cosmo Pharmaceuticals N.V.
LevelJump Announces Reinstatement of Trading on the TSX Venture Exchange and Provides Corporate Updates
Toronto, Ontario--(Newsfile Corp. - October 6, 2025) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company") is pleased to announce that, further to its press release of June 24, 2025, trading on the TSX Venture Exchange (the "Exchange") will resume with trading expected to be reinstated on or about October 9, 2025. Disclosure relating to the Company's activities during the past 12 months (including an annual information form) is readily av
Healthcare and Hospitals, Health
2025-10-06 6:45 PM EDT | LevelJump Healthcare Corp.
Adia Nutrition Inc. Divests Biolete Coffee Subsidiary to Cement Factory LLC, Retains 18% Ownership to Support Strategic Focus on Regenerative Medicine and Medical Sales
Winter Park, Florida--(Newsfile Corp. - October 6, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), an emerging leader in regenerative medicine and innovative healthcare solutions, today announced the sale of its Biolete coffee subsidiary to Cement Factory LLC, a dynamic consumer products firm led by key owners Jeff Sciullo and AJ Sims. Adia will retain an 18% ownership stake in Cement Factory LLC, ensuring continued alignment with Biolete's growth while enabling Adia to concentrate resources on it
Healthcare and Hospitals, Health
2025-10-06 12:39 PM EDT | Adia Nutrition Inc.
White-Wilson Medical Center, PA Initiates Voluntary Chapter 11 Process to Strengthen Financial Foundation and Continue Serving Florida's Emerald Coast
Fort Walton Beach, Florida--(Newsfile Corp. - October 6, 2025) - White-Wilson Medical Center, P.A. ("White-Wilson", the "Debtor" or the "Company"), a multi-specialty physician group serving Florida's Emerald Coast for more than 79 years, today announced that it has voluntarily filed a petition for reorganization under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the Northern District of Florida. The case has been assigned to the Honorable Karen K. Specie, C
2025-10-06 9:24 AM EDT | White Wilson Medical Center & Johnson Pope Bokor Rupple & Burns, LLP
MyndTec Inc. Completes Fifth Tranche of Non-Brokered Private Placement
Mississauga, Ontario--(Newsfile Corp. - October 2, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), a neurological treatment and rehabilitation medical technology company, is pleased to announce that it has closed the fifth tranche of its non-brokered private placement previously announced on January 30, 2025 (the "Offering"). The fifth tranche of the private placement consists of 522,106 Units of the Company (the "Un
Technology, Healthcare and Hospitals, Health
2025-10-02 6:00 PM EDT | MyndTec Inc.
CardioComm Solutions Announces Royalty-Based Financing Deal
Toronto, Ontario--(Newsfile Corp. - October 1, 2025) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announces that it has entered into a royalty-based financing arrangement (the "Royalty Agreement") with current debt lenders to the Company (the "Lenders") in order secure new capital required to complete and commercialize the Company'
Technology, Healthcare and Hospitals, Health
2025-10-01 11:55 PM EDT | CardioComm Solutions, Inc.
AmeriHealth Caritas Names Gregg MacDonald Interim President
Newtown Square, Pennsylvania--(Newsfile Corp. - October 1, 2025) - AmeriHealth Caritas today announced that Gregg MacDonald has been appointed interim president, effective immediately.
2025-10-01 10:30 AM EDT | AmeriHealth Caritas
Envoy Medical to Participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) Conference on October 11th-14th
White Bear Lake, Minnesota--(Newsfile Corp. - October 1, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced that management will participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) conference taking place on October 11th-14th, 2025 in Indianapolis, IN, at the Indiana Convention Center and JW Marriott Indianapolis
Biotechnology, Healthcare and Hospitals
2025-10-01 8:00 AM EDT | Envoy Medical, Inc.
Scryb Grants Stock Options
Toronto, Ontario--(Newsfile Corp. - September 30, 2025) - Scryb Inc. (CSE: SCYB) (OTC Pink: SCYRF) (FSE: EIY) ("Scryb'' or the "Company") announces that it has granted 3,870,000 stock options (the "Options") to various employees, directors, officers and consultants of the Company. Each Option is exercisable at a price of $0.12 for one common share of the Company (each a "Common Share") for a period of five years from the da
Biotechnology, Healthcare and Hospitals, Health
2025-09-30 8:04 PM EDT | Scryb Inc.
Discovery Senior Living Completes New Texas Assisted Living & Memory Care Development; Delivers Quick Lease-Up of Castle Hills Expanded Campus
Bonita Springs, Florida--(Newsfile Corp. - September 30, 2025) - Discovery Senior Living ("Discovery" or the "Company") and its affiliated subsidiaries, one of the most trusted and the largest privately held senior housing operator in the U.S., is pleased to announce the opening and rapid early lease-up of its newest development, Discovery Village Castle Hills Assisted Living and Memory Care. The expansion marks a rare ground-up senior housing development completed during the last few
Healthcare and Hospitals, Real Estate, Housing
2025-09-30 9:33 AM EDT | Discovery Senior Living
Discovery Senior Living Leader Recognized with 2025 Memory Care Innovation Award for Advancing Cognitive Care Across 200+ Communities Nationwide
Bonita Springs, Florida--(Newsfile Corp. - September 29, 2025) - Discovery Senior Living ("Discovery", the "Company") and its affiliates, one of the most trusted and largest privately held senior living operators, has been named a 2025 Memory Care Innovation Award winner in the Senior Housing & Senior Living category by WTWH Healthcare. The award celebrates people in organizations pushing the boundaries of cognitive care delivery and improving outcomes for individuals living with m
Healthcare and Hospitals, Real Estate, Housing
2025-09-29 4:45 PM EDT | Discovery Senior Living
BioMark Secures Key Patents in Asia's Largest Markets for Early Lung Cancer Liquid Biopsy
Vancouver, British Columbia--(Newsfile Corp. - September 29, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a leading developer of liquid biopsy technologies for early cancer detection, is pleased to announce the formal grant of patents in both China and Japan. These new patents cover its innovative metabolic liquid biopsy platform for the rapid, non-invasive detection of lung cancer. The newly granted Chinese patent (N° ZL 201980092723.X) a
Technology, Biotechnology, Healthcare and Hospitals
2025-09-29 8:30 AM EDT | BioMark Diagnostics, Inc.
Scryb Closes Oversubscribed Private Placement for over $1.4M
Toronto, Ontario--(Newsfile Corp. - September 26, 2025) - Scryb Inc. (CSE: SCYB) ("Scryb" or the "Company"), is pleased to announce it has completed its previously announced upsized non-brokered private placement offering, issuing 14,709,700 units of the Company (each, a "Unit"), at a price of $0.10 per Unit, for gross proceeds of $1,470,970 (the "Offering"). The original offering was announced for up to 6,000,000 Units of the Company on September 17, 2025, and
Biotechnology, Healthcare and Hospitals, Health
2025-09-26 7:03 PM EDT | Scryb Inc.
AmeriHealth Caritas SVP Joins UN Science Summit Panel to Promote Action on Brain Health Equity
New York, New York--(Newsfile Corp. - September 26, 2025) - Dr. Joy Bland, senior vice president of quality & health equity at AmeriHealth Caritas, joined leading experts in health care and innovation at the Science Summit of the 80th United Nations General Assembly to explore how to turn growing awareness of brain health into meaningful, large-scale progress. Brain health – including mental health, neurological disorders, and cognitive conditions – has become
2025-09-26 6:07 PM EDT | AmeriHealth Caritas
NuGen Medical Devices Announces NHS Drug Tariff Approval for EziAutoJector(R) Product Line in the UK
Toronto, Ontario--(Newsfile Corp. - September 26, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, is pleased to announce that its exclusive UK distribution partner, EziAutoJector® Ltd, has received confirmation from the NHS Business Services Authority, on behalf of the Department of Health, that EziAutoJector® products have been approved for inclusion in the NHS Drug Tariff.
Healthcare and Hospitals, Pharmaceuticals, Health
2025-09-26 5:30 PM EDT | NuGen Medical Devices Inc.
CardioComm Solutions Inc. Announces Insider Purchase of Third-party Loan
Toronto, Ontario--(Newsfile Corp. - September 26, 2025) - CardioComm Solutions Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, today announced that its Chief Executive Officer, Mr. Etienne Grima, has purchased from one of the Company's lenders a loan with a principal value of $80,000 (the "Loan"). The Loan represents a portion of original loans totaling $600,000, which were first a
Technology, Healthcare and Hospitals, Health
2025-09-26 1:40 PM EDT | CardioComm Solutions, Inc.
Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors
Ontario and Chicago, Illinois--(Newsfile Corp. - September 25, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today held its virtual annual meeting of shareholders. Medexus shareholders elected all nominees listed in Medexus's management information circular dated August 12, 2025 as directors through the next annual meeting. Shareholders also voted in favor of the appointment of PricewaterhouseCoopers LLP as the company's auditors. Detailed voting results for the ele
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-09-25 5:30 PM EDT | Medexus Pharmaceuticals Inc.
Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
White Bear Lake, Minnesota--(Newsfile Corp. - September 25, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of 1,908,402 shares of its Class A common stock at a purchase price of $1.31 per share of Class A common stock. In addition, in a concurrent private plac
Biotechnology, Healthcare and Hospitals
2025-09-25 8:00 AM EDT | Envoy Medical, Inc.
HEALWELL Provides Corporate Update Reflecting Integration Progress and Global Launch of AmadeusAI - the Company's Next Generation AI Enabled Digital Care Record
HEALWELL achieves an exciting integration milestone and announces the global launch of AmadeusAI, now deeply integrated with DARWEN™ AI, providing healthcare providers with advanced artificial intelligence capabilities to analyze structured and unstructured clinical data, identify at-risk patients, and support timely, informed decisions at the point of care. The platform includes HEALWELL's SMARTSuite of AI tools, including SMARTSearch, SMARTS
Technology, Healthcare and Hospitals
2025-09-25 3:15 AM EDT | HEALWELL AI